Could psychedelics help patients in therapy? ...

In this season of WorkLife, we’re pairing each of our regular episodes with a companion interview to do a deeper dive into the topic. This is the companion for our episode on the secrets of a great apology. Michael McCullough is a psychology professor at UC San Diego and a pionee ...  Show more

When has healthcare advice become so complicated? And how should we be thinking about long-term wellness? Zeke Emanuel is an oncologist and bioethnicist whose latest book, Eat Your Ice Cream, might sound paradoxical against modern health trends and wellness noise. Zeke joins Shos ...  Show more

Send us Fan MailThe path to FDA approved prescribable medicine has been a long and precarious one for psychedelics. However, recent reports by some of the major players in the psychedelic medicine space show promising results from clinical trials involving psilocybin and 5-MeO-DM ...  Show more

<span style= "font-size: 10.0pt; mso-bidi-font-family: Arial; mso-bidi-font-style: italic;"> What do the clinical trials of psilocybin and other psychedelics show in terms of efficacy and safety? How much of the benefit with psychedelic treatment is attributa ...

In this Huberman Lab Essentials episode, my guest is Dr. Matthew Johnson, PhD, a senior researcher for the Center of Excellence for Psilocybin Research and Treatment at Sheppard Pratt’s Institute for Advanced Diagnostics and Therapeutics. We explore the science and therapeutic po ...  Show more

The psychedelic revolution

Will LSD, Psilocybin, MDMA, and Ketamine treatments live up to the hype?

For decades, psychedelics were derided as dangerous recreational drugs; now many claim they have the potential to revolutionise the treatment of men ...